# Trustco Bank Corp N Y: financial statements, quarterly

TRST · Nasdaq · CIK 357301 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trst.md) · [Financials](/companies/trst/financials.md) · [Filings](/companies/trst/filings.md) · [Insiders](/companies/trst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/trst/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [15.3](/filings/0001140361-23-052098.md) | [20.0 d](/filings/0001140361-24-012641.md) | [23.2](/filings/0001140361-24-025190.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.6](/filings/0001140361-24-045861.md) | [3.1 d](/filings/0001140361-26-009576.md) | [3.8](/filings/0001140361-25-018154.md) | [3.9](/filings/0001140361-25-029804.md) | [4.0](/filings/0001140361-25-041145.md) | [3.5 d](/filings/0001140361-26-009576.md) | [4.4](/filings/0001140361-26-020000.md) | [4.7](/filings/0001140361-26-031982.md) | [5.1](/filings/0001140361-25-041145.md) | [5.5 d](/filings/0001140361-26-009576.md) | [5.3](/filings/0001140361-26-020000.md) | [5.6](/filings/0001140361-26-031982.md) |
| Net income | $m | [14.7](/filings/0001140361-24-045861.md) | [9.8 d](/filings/0001140361-26-009576.md) | [12.1](/filings/0001140361-25-041145.md) | [12.6](/filings/0001140361-25-041145.md) | [12.9](/filings/0001140361-25-041145.md) | [11.3 d](/filings/0001140361-26-009576.md) | [14.3](/filings/0001140361-26-031982.md) | [15.0](/filings/0001140361-26-031982.md) | [16.3](/filings/0001140361-25-041145.md) | [15.6 d](/filings/0001140361-26-009576.md) | [16.3](/filings/0001140361-26-031982.md) | [17.0](/filings/0001140361-26-031982.md) |
| Diluted EPS | $ per share | [0.77](/filings/0001140361-24-045861.md) | not reported | [0.64](/filings/0001140361-25-018154.md) | [0.66](/filings/0001140361-25-029804.md) | [0.68](/filings/0001140361-25-041145.md) | not reported | [0.75](/filings/0001140361-26-020000.md) | [0.79](/filings/0001140361-26-031982.md) | [0.86](/filings/0001140361-25-041145.md) | not reported | [0.91](/filings/0001140361-26-020000.md) | [0.98](/filings/0001140361-26-031982.md) |
| Basic EPS | $ per share | [0.77](/filings/0001140361-24-045861.md) | not reported | [0.64](/filings/0001140361-25-018154.md) | [0.66](/filings/0001140361-25-029804.md) | [0.68](/filings/0001140361-25-041145.md) | not reported | [0.75](/filings/0001140361-26-020000.md) | [0.79](/filings/0001140361-26-031982.md) | [0.87](/filings/0001140361-25-041145.md) | not reported | [0.91](/filings/0001140361-26-020000.md) | [0.98](/filings/0001140361-26-031982.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [507](/filings/0001140361-23-052098.md) | [578](/filings/0001140361-25-008827.md) | [610](/filings/0001140361-24-025190.md) | [536](/filings/0001140361-24-036598.md) | [523](/filings/0001140361-24-045861.md) | [642](/filings/0001140361-26-009576.md) | [756](/filings/0001140361-25-018154.md) | [714](/filings/0001140361-25-029804.md) | [696](/filings/0001140361-25-041145.md) | [730](/filings/0001140361-26-031982.md) | [768](/filings/0001140361-26-020000.md) | [697](/filings/0001140361-26-031982.md) |
| Total assets | $m | [6,054](/filings/0001140361-23-052098.md) | [6,168](/filings/0001140361-25-008827.md) | [6,180](/filings/0001140361-24-025190.md) | [6,107](/filings/0001140361-24-036598.md) | [6,110](/filings/0001140361-24-045861.md) | [6,239](/filings/0001140361-26-009576.md) | [6,339](/filings/0001140361-25-018154.md) | [6,348](/filings/0001140361-25-029804.md) | [6,349](/filings/0001140361-25-041145.md) | [6,441](/filings/0001140361-26-031982.md) | [6,508](/filings/0001140361-26-020000.md) | [6,525](/filings/0001140361-26-031982.md) |
| Total liabilities | $m | [5,430](/filings/0001140361-23-052098.md) | [5,523](/filings/0001140361-25-008827.md) | [5,530](/filings/0001140361-24-025190.md) | [5,451](/filings/0001140361-24-036598.md) | [5,441](/filings/0001140361-24-045861.md) | [5,562](/filings/0001140361-26-009576.md) | [5,651](/filings/0001140361-25-018154.md) | [5,656](/filings/0001140361-25-029804.md) | [5,657](/filings/0001140361-25-041145.md) | [5,754](/filings/0001140361-26-031982.md) | [5,837](/filings/0001140361-26-020000.md) | [5,869](/filings/0001140361-26-031982.md) |
| Short-term borrowings | $m | [103](/filings/0001140361-23-052098.md) | [89.0](/filings/0001140361-25-008827.md) | [94.4](/filings/0001140361-24-025190.md) | [89.7](/filings/0001140361-24-036598.md) | [91.5](/filings/0001140361-24-045861.md) | [84.8](/filings/0001140361-26-009576.md) | [82.3](/filings/0001140361-25-018154.md) | [82.4](/filings/0001140361-25-029804.md) | [97.7](/filings/0001140361-25-041145.md) | [120](/filings/0001140361-26-031982.md) | [113](/filings/0001140361-26-020000.md) | [108](/filings/0001140361-26-031982.md) |
| Shareholders' equity | $m | [624](/filings/0001140361-24-045861.md) | [645](/filings/0001140361-26-009576.md) | [649](/filings/0001140361-25-041145.md) | [655](/filings/0001140361-25-041145.md) | [669](/filings/0001140361-25-041145.md) | [676](/filings/0001140361-26-031982.md) | [688](/filings/0001140361-26-031982.md) | [693](/filings/0001140361-26-031982.md) | [692](/filings/0001140361-25-041145.md) | [687](/filings/0001140361-26-031982.md) | [671](/filings/0001140361-26-031982.md) | [656](/filings/0001140361-26-031982.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.9 d](/filings/0001140361-24-045861.md) | [17.8 d](/filings/0001140361-26-009576.md) | [9.9](/filings/0001140361-25-018154.md) | [18.7 d](/filings/0001140361-25-029804.md) | [16.5 d](/filings/0001140361-25-041145.md) | [14.3 d](/filings/0001140361-26-009576.md) | [1.3](/filings/0001140361-26-020000.md) | [27.1 d](/filings/0001140361-26-031982.md) | [12.8 d](/filings/0001140361-25-041145.md) | [16.5 d](/filings/0001140361-26-009576.md) | [11.8](/filings/0001140361-26-020000.md) | [28.0 d](/filings/0001140361-26-031982.md) |
| Capital expenditure | $m | [0.8 d](/filings/0001140361-24-045861.md) | [3.0 d](/filings/0001140361-26-009576.md) | [0.5](/filings/0001140361-25-018154.md) | [1.1 d](/filings/0001140361-25-029804.md) | [0.9 d](/filings/0001140361-25-041145.md) | [2.3 d](/filings/0001140361-26-009576.md) | [4.5](/filings/0001140361-26-020000.md) | [2.1 d](/filings/0001140361-26-031982.md) | [2.8 d](/filings/0001140361-25-041145.md) | [2.4 d](/filings/0001140361-26-009576.md) | [1.6](/filings/0001140361-26-020000.md) | [2.5 d](/filings/0001140361-26-031982.md) |
| Dividends paid | $m | [6.8 d](/filings/0001140361-24-045861.md) | [6.9 d](/filings/0001140361-26-009576.md) | [6.8](/filings/0001140361-25-018154.md) | [6.8 d](/filings/0001140361-25-029804.md) | [6.9 d](/filings/0001140361-25-041145.md) | [6.9 d](/filings/0001140361-26-009576.md) | [6.8](/filings/0001140361-26-020000.md) | [6.8 d](/filings/0001140361-26-031982.md) | [6.8 d](/filings/0001140361-25-041145.md) | [7.1 d](/filings/0001140361-26-009576.md) | [6.8](/filings/0001140361-26-020000.md) | [6.7 d](/filings/0001140361-26-031982.md) |
| Share repurchases | $m | [0.0 d](/filings/0001140361-24-045861.md) | [0.0 d](/filings/0001140361-26-009576.md) | not reported | not reported | [0.0 d](/filings/0001140361-25-041145.md) | [0.0 d](/filings/0001140361-26-009576.md) | [0.0](/filings/0001140361-26-020000.md) | [5.3 d](/filings/0001140361-26-031982.md) | [11.5 d](/filings/0001140361-25-041145.md) | [21.3 d](/filings/0001140361-26-009576.md) | [23.9](/filings/0001140361-26-020000.md) | [24.6 d](/filings/0001140361-26-031982.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.1](/filings/0001140361-23-052098.md) | [19.0](/filings/0001140361-24-025190.md) | [19.0](/filings/0001140361-24-036598.md) | [19.0](/filings/0001140361-24-045861.md) | [19.0](/filings/0001140361-25-018154.md) | [19.0](/filings/0001140361-25-029804.md) | [19.0](/filings/0001140361-25-041145.md) | [19.0](/filings/0001140361-26-020000.md) | [19.0](/filings/0001140361-26-031982.md) | [18.8](/filings/0001140361-25-041145.md) | [17.9](/filings/0001140361-26-020000.md) | [17.4](/filings/0001140361-26-031982.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,027,740 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001140361-26-031982.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.